Skip to main content
Top
Published in: Journal of Radiation Oncology 4/2015

01-12-2015 | Announcement

The Journal of Radiation Oncology is inviting investigators to submit their clinical trial proposals for publication

Published in: Journal of Radiation Oncology | Issue 4/2015

Login to get access

Excerpt

The Journal of Radiation Oncology is pleased to announce that the journal is now encouraging and accepting submissions of clinical trial proposals as a featured manuscript type for publication. There are several advantages to publishing your clinical trial’s proposal, before its accrual and data maturation:
  • It provides an opportunity for an extramural review of your trial proposal, to ensure that all aspects have been vetted and solidified by the recommendations and suggestions of multiple expert reviewers.
  • It shares with the radiation oncology community the direction of your clinical program and may inspire or assist others in their own clinical trial design.
  • It assures that the clinical questions you seek to address are cutting-edge and in-step with the overall direction of the field at large.
  • Lastly, it may foster potential multi-institutional collaborations among the Journal of Radiation Oncology’s readership, improving the statistical robustness and generalizability of your clinical trial’s eventual findings.
Metadata
Title
The Journal of Radiation Oncology is inviting investigators to submit their clinical trial proposals for publication
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Radiation Oncology / Issue 4/2015
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-015-0229-0

Other articles of this Issue 4/2015

Journal of Radiation Oncology 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine